Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

Journal of breast cancer·2026

Same author

Integration of multi-omics for precision therapy in breast cancer.

Drug discovery today·2026

Same author

Navigating luminal heterogeneity: etiology-based proteogenomic subtyping for targeted treatment strategies in breast cancer.

Molecular cancer·2026

Same author

Decoding the S1P-S1PR axis in cancer: Mechanisms, pathways and therapeutic horizons (Review).

Biomedical reports·2026

Same author

TREAT-Netv2: regional wall motion-informed video-tabular fusion for ACS treatment prediction.

International journal of computer assisted radiology and surgery·2026

Same author

Tribo-Electromagnetic Nanogenerator Based on Microstructured Polyvinyl Chloride Layer for Enhanced Hybrid Energy Harvesting and Intelligent Health Monitoring.

Small (Weinheim an der Bergstrasse, Germany)·2026

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Dielectrophoresis-based cellular microarray chip for anticancer drug screening in perfusion microenvironments.

Lo-Chang Hsiung¹, Chi-Ling Chiang, Chen-Ho Wang

¹Institute of Applied Mechanics, National Taiwan University, Taipei, Taiwan.

|June 2, 2011

Summary

This study introduces a dielectrophoresis (DEP) chip for anticancer drug screening, using fewer cells and achieving results comparable to traditional methods. The microfluidic chip enables efficient cell patterning and drug testing in perfusion environments.

More Related Videos

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Published on: May 21, 2019

Related Experiment Videos

Last Updated: Jun 1, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Published on: May 21, 2019

Area of Science:

Biomedical Engineering
Microfluidics
Cell Biology

Background:

Anticancer drug screening requires efficient and reproducible cell-based assays.
Microfluidic systems offer potential for improved cell culture and drug testing.
Dielectrophoresis (DEP) is a technique used for manipulating cells.

Purpose of the Study:

To develop and validate a DEP-based cellular microarray chip for anticancer drug screening.
To assess the chip's performance in terms of cell patterning, drug concentration generation, and dose-response accuracy.
To compare the chip's efficacy with traditional 96-well plate assays.

Main Methods:

Human breast cancer cells (MCF7) were patterned onto planar interdigitated ring electrode (PIRE) arrays using DEP forces.
A concentration gradient generator (CGG) and anti-crosstalk valve (ACV) were integrated for stable drug concentration generation.
Cells were treated with cisplatin or docetaxel for 24 hours, and viability was assessed using dual staining.

Main Results:

High uniformity in cell patterning was achieved (92 ± 5 cells per PIRE).
No significant difference in dose-responses was observed between the DEP chip and 96-well plate controls.
The chip demonstrated reproducible drug responses and IC(50) values consistent with literature.

Conclusions:

The DEP-based microarray chip is a viable tool for cell-based anticancer drug screening, requiring fewer cells.
The chip's perfusion microenvironment supports reproducible drug response analysis.
This technology has potential applications in drug discovery and personalized medicine, especially when cell supply is limited.